1983
DOI: 10.2307/3429545
|View full text |Cite
|
Sign up to set email alerts
|

Preneoplastic and Neoplastic Progression during Hepatocarcinogenesis in Mice Injected with Diethylnitrosamine in Infancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
10
0
1

Year Published

1995
1995
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 11 publications
4
10
0
1
Order By: Relevance
“…The occurrence, growth and evolution of DEN-induced mouse hepatic proliferative and neoplastic lesions depends on several factors including the dose scheme and administration route of DEN and also age, strain and gender of mice (1,2). Our finding of hepatocellular adenomas in 10-months-old C56BL/6 male mice that were treated with 5 mg/kg BW of DEN matches the results of other published studies using mice of comparable genetic backgrounds and the same gender and similar experimental designs (6,29).…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…The occurrence, growth and evolution of DEN-induced mouse hepatic proliferative and neoplastic lesions depends on several factors including the dose scheme and administration route of DEN and also age, strain and gender of mice (1,2). Our finding of hepatocellular adenomas in 10-months-old C56BL/6 male mice that were treated with 5 mg/kg BW of DEN matches the results of other published studies using mice of comparable genetic backgrounds and the same gender and similar experimental designs (6,29).…”
Section: Discussionsupporting
confidence: 81%
“…Among them, the chemically induced model that utilizes diethylnitrosamine (DEN) for HCC initiation is widely used and well-characterized. This model recapitulates aspects of liver injury and fibrosis and hepatitis, which both are the basis of human HCC (1,2,4,6). For that, and because it is comparable to its human counterpart in terms of cancer-associated gene expression patterns and carcinogenetic pathways, it is considered among the best-fit experimental models of HCC (5).…”
Section: Introductionmentioning
confidence: 99%
“…However, the quantitative difference in UG promotion activity between male and female mice most likely is, in part, a consequence of the 16-week time point chosen for analysis. AHF in the DEN/control group were about fourfold larger in male than in female mice at this time point (11), which is consistent with the well-established faster growth of AHF in male mice in the infant mouse model (28,29). Thus, it would have been relatively difficult to demonstrate the same fourfold increase in size of AHF in male versus female mice at the 16-week time point.…”
Section: Discussionsupporting
confidence: 50%
“…UG did not increase nonlesioned hepatocyte LI in initiation control or DEN-initiated mice (Table 3). The hepatocyte LI of AHF was substantially greater than that of nonlesioned liver, as expected (27)(28)(29). The mean hepatocyte LI of AHF from DEN/UG-treated mice was 29% greater (p < 0.01) than the mean hepatocyte LI of AHF from mice treated with DEN alone (Table 3).…”
mentioning
confidence: 62%
“…In CDF1 mice, the sensitivity of females to the induction of liver tumor was approximately twice that of males . Because it is well known that oval cell proliferation and basophilic foci are induced by hepatocarcinogens (Goldfarb et al, 1983;He et al, 1994), female rasH2 mice are considered to be more sensitive to hepatocarcinogenesis induced by IQ than male rasH2 mice, as in the case of CDF1 mice. IQ is metabolized by cytochrome P450 (CYP) 1A2 mainly in the liver and induces its activating enzyme (Nerurkar et al, 1993).…”
Section: Discussionmentioning
confidence: 99%